Search results
Big Pharma layoffs continue, as Bristol-Myers Squibb cuts 2,200 jobs, $1.5B in costs
BenefitsPRO· 6 days agoBristol-Myers Squibb has announced that it plans to cut $1.5 billion in expenses by the end of 2025,...
Is Novavax Stock A Buy After Nearly Tripling On $1.3 Billion Sanofi Deal?
Investor's Business Daily· 2 days agoShares now have a top Relative Strength Rating of 99. The RS Rating pits all stocks, regardless of...
The changing face of the Dow: See the names that have come and gone on the path to 40,000
CNBC· 9 hours agoMany companies have been added and removed in the more than 125 years of the Dow's existence.
NHS offers life-saving drug for stiff heart condition
BBC via Yahoo News· 4 days ago"This pioneering drug is just one example of the NHS delivering on its commitment to ensure patients...
Reduced Breast Cancer Mortality: Screen, Prevent, Treat
Medscape· 4 days agoDr Maurie Markman discusses results from a modeling study investigating the reduction in breast...
JD Supra: Out from the Shadows: The SEC Succeeds on Shadow Insider Trading Theory
JD Supra· 8 hours agoThe Securities and Exchange Commission obtained a victory in a closely-watched trial when a jury found Matthew Panuwat liable for insider trading based on a “shadow trading” theory. The jury ...
Daily Brief: The Nvidia Rush
Quartz· 3 days agoFrance got a $16 billion cash infusion from the likes of Microsoft, Amazon, and Pfizer. Gold is still the first choice for many investors looking to...
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher?
Motley Fool via Yahoo Finance· 3 days agoThe Novavax COVID-19 vaccine, which is called Nuvaxovid outside of the U.S., isn't like the mRNA...
7 F-Rated Stock Picks to Avoid Like the Plague in May
InvestorPlace via Yahoo Finance· 7 days agoThe stock market is off to a washing machine kind of start for 2024, with gains and lulls that keep...
Daily Brief: Quadruple the tariffs
Quartz· 3 days agoThe new tariffs, aimed at China’s electric vehicle makers, would make any automaker sweat. They’re slated to reach as high as 102.5%, up from 27.5%.